4.6 Article

TGFβ1 induces apoptosis in invasive prostate cancer and bladder cancer cells via Akt-independent, p38 MAPK and JNK/SAPK-mediated activation of caspases

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2012.09.035

Keywords

Prostate cancer; TGF beta; Apoptosis; P38 MAPK; JNK; Akt

Funding

  1. University of Georgia Research Foundation
  2. Wilson Pharmacy Foundation
  3. UGA College of Pharmacy
  4. National Institutes of Health [R01HL103952]
  5. American Heart Association Scientist Development Grant [0830326N]

Ask authors/readers for more resources

Recent findings indicate that advanced stage cancers shun the tumor suppressive actions of TGF beta and inexplicably utilize the cytokine as a tumor promoter. We investigated the effect of TGF beta 1 on the survival and proliferation of invasive prostate (PC3) and bladder (T24) cancer cells. Our study indicated that TGF beta 1 decreased cell viability and induced apoptosis in invasive human PC3 and 124 cells via activation of p38 MAPK-JNK-Caspase9/8/3 pathway. Surprisingly, no change in the phosphorylation of pro-survival Akt kinase was observed. We postulate that TGF beta 1 pathway may be utilized for specifically targeting urological cancers without inflicting side effects on normal tissues. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available